Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

aXichem

2.76

 

SEK

 

-1.08 %

Less than 1K followers

AXIC A

First North Stockholm

Chemicals

Basic Materials

Overview
Ownership
Investor consensus

aXichem is active in industrial biotechnology. The company develops, patents and markets industrial chemicals. The company mainly works with Phenylcapsaicin, a natural analog synthetic capsaicin with applications in a variety of areas, such as in the marine sector, among pest control in forestry and agriculture, as well as among individual pharmaceutical work areas. Operations are run on a global level, with the head office in Malmö.

Read more
Market cap
163.16M SEK
Turnover
38.69K SEK
Revenue
8.57M
EBIT %
-184.71 %
P/E
-
Dividend yield-%
-
Financial calendar
18/6
2025

General meeting '25

28/8
2025

Interim report Q2'25

28/11
2025

Interim report Q3'25

All
Press releases
3rd party
ShowingAll content types
Press release6/12/2025, 6:30 AM

aXichem AB: aXichem meddelar positiva resultat av genomförda effektstudier, samt tid för inlämning av kompletterad Feed Additive-ansökan i EU

aXichem
Press release6/12/2025, 6:30 AM

aXichem AB: aXichem announces positive results of completed efficacy studies, as well as time for submission of supplemented Feed Additive application in the EU

aXichem
Regulatory press release5/28/2025, 7:00 AM

aXichem AB (publ) publicerar Årsredovisning 2024

aXichem

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/28/2025, 7:00 AM

aXichem AB (publ) publishes Annual Report 2024

aXichem
Third party research5/23/2025, 2:02 PM

aXichem: Lovande start på 2025 - VH Corp

* Order i Q1 och första avrop i Q2 från Chr. Olesen * Positiva preliminära resultat från Cross-Fit Performance-studien * Vi har höjt vårt motiverade värde till 2,95 (2,50) SEK per aktie Sedan årsskiftet har aXichems aktiekurs gått starkt och både marknaden...

aXichem
Press release5/23/2025, 2:00 PM

Västra Hamnen Market Focus: aXichem: Lovande start på 2025

aXichem
Regulatory press release5/22/2025, 6:30 AM

aXichem AB (publ), delårsrapport januari - mars 2025

aXichem
Regulatory press release5/22/2025, 6:30 AM

aXichem AB (publ), Interim Report January - March 2025

aXichem
Press release5/19/2025, 3:00 PM

aXichem AB: aXichems VD Torsten Helsing presenterar rapport för första kvartalet 2025 i en direktsänd webbkonferens

aXichem
Press release5/19/2025, 3:00 PM

aXichem AB: aXichem's CEO Torsten Helsing Presents the Report for the First Quarter 2025 in a Live Web Conference

aXichem
Regulatory press release5/16/2025, 5:30 AM

aXichem AB: NOTICE OF ANNUAL GENERAL MEETING IN AXICHEM AB (PUBL)

aXichem
Regulatory press release5/16/2025, 5:30 AM

aXichem AB: KALLELSE TILL ÅRSSTÄMMA I AXICHEM AB (PUBL)

aXichem
Press release5/12/2025, 6:30 AM

aXichem AB: aXichem receives first call-off order for aXiphen[ ]from Chr. Olesen after successful tests in Brazil

aXichem
Press release5/12/2025, 6:30 AM

aXichem AB: aXichem får första avropsordern för aXiphen från Chr. Olesen efter framgångsrika tester i Brasilien

aXichem
Press release4/28/2025, 7:00 AM

aXichem AB: aXivite driver rekordefterfrågan då Triquetra Healths GLP-Activate[™] klättrar till toppförsäljning

aXichem
Press release4/28/2025, 7:00 AM

aXichem AB: aXivite fuels record demand as Triquetra Health's GLP-Activate[™] climbs to top-seller status

aXichem
Press release4/16/2025, 6:50 AM

aXichem AB: aXichem utser Erik Lager till Chief Operating Officer, för att möta tillväxtfasens ökade behov av en kvalitetssäkrad leveransprocess

aXichem
Press release4/16/2025, 6:50 AM

aXichem AB: aXichem appoints Erik Lager as Chief Operating Officer, to meet the growth phase's increased need for a quality-assured delivery process

aXichem
Press release3/18/2025, 7:30 AM

aXichem AB: aXichem upptar kreditfacilitet med stöd från EIF, för fortsatt etablering av aXiphen i Brasilien

aXichem
Press release3/18/2025, 7:30 AM

aXichem AB: aXichem takes up credit facility with support from EIF, for continued establishment of aXiphen in Brazil

aXichem
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team